Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 4, 2024
Induction cyclophosphamide with maintenance immunosuppression in high-risk myasthenia gravis: long-term follow-up and safety profile
Fiona Chan, Todd A Hardy, Sameer Malik, et al.
Muscle & Nerve
|
December 10, 2014
Induction intravenous cyclophosphamide followed by maintenance oral immunosuppression in refractory myasthenia gravis
Katherine A Buzzard, Nicholas J Meyer, Todd A Hardy, et al.
Muscle & Nerve
|
June 10, 2019
Association between musk antibody concentrations and the myasthenia gravis composite score in 3 patients: A marker of relapse?
James D Triplett, Todd A Hardy, D Sean Riminton, et al.
Neurology
|
August 28, 2019
The spectrum of immune-mediated and inflammatory lesions of the brainstem: Clues to diagnosis
Lai Yin Law, D Sean Riminton, MaiAnh Nguyen, et al.
The Journal of Experimental Medicine
|
June 6, 1998
Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice
D Sean Riminton, H Körner, D H Strickland, et al.
Journal of Neurology
|
December 31, 2014
Distinguishing Susac's syndrome from multiple sclerosis
Katherine A Buzzard, Stephen W Reddel, Con Yiannikas, et al.
European Journal of Immunology
|
July 13, 2002
Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs
Patricia Wilhelm, D Sean Riminton, Uwe Ritter, et al.
Journal of Neuroimmunology
|
September 10, 2017
A systematic checklist approach to immunosuppression risk management: An audit of practice at two clinical neuroimmunology centers
Amelia M Mori, Smriti Agarwal, Monique W M Lee, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 11, 2015
The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases
Nidhi Garg, Stephen W Reddel, David H Miller, et al.
The Journal of Allergy and Clinical Immunology
|
August 4, 2012
Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22)
Gary Y J Chew, Umang Sinha, Paul A Gatenby, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 4, 2024
Induction cyclophosphamide with maintenance immunosuppression in high-risk myasthenia gravis: long-term follow-up and safety profile
Fiona Chan, Todd A Hardy, Sameer Malik, et al.
Muscle & Nerve
|
December 10, 2014
Induction intravenous cyclophosphamide followed by maintenance oral immunosuppression in refractory myasthenia gravis
Katherine A Buzzard, Nicholas J Meyer, Todd A Hardy, et al.
Muscle & Nerve
|
June 10, 2019
Association between musk antibody concentrations and the myasthenia gravis composite score in 3 patients: A marker of relapse?
James D Triplett, Todd A Hardy, D Sean Riminton, et al.
Neurology
|
August 28, 2019
The spectrum of immune-mediated and inflammatory lesions of the brainstem: Clues to diagnosis
Lai Yin Law, D Sean Riminton, MaiAnh Nguyen, et al.
The Journal of Experimental Medicine
|
June 6, 1998
Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice
D Sean Riminton, H Körner, D H Strickland, et al.
Journal of Neurology
|
December 31, 2014
Distinguishing Susac's syndrome from multiple sclerosis
Katherine A Buzzard, Stephen W Reddel, Con Yiannikas, et al.
European Journal of Immunology
|
July 13, 2002
Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs
Patricia Wilhelm, D Sean Riminton, Uwe Ritter, et al.
Journal of Neuroimmunology
|
September 10, 2017
A systematic checklist approach to immunosuppression risk management: An audit of practice at two clinical neuroimmunology centers
Amelia M Mori, Smriti Agarwal, Monique W M Lee, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 11, 2015
The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases
Nidhi Garg, Stephen W Reddel, David H Miller, et al.
The Journal of Allergy and Clinical Immunology
|
August 4, 2012
Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22)
Gary Y J Chew, Umang Sinha, Paul A Gatenby, et al.
Page
of 3